Vaghela Joins Research Solutions Subsidiary Reprints Desk from Pharmaceutical Drug Safety Software Division at ProQuest LLC
ENCINO, Calif., January 11, 2017 — Research Solutions, Inc., (OTCQB: RSSS), a pioneer in providing cloud-based solutions for scientific research, has appointed Raj Vaghela to Director of Product Management for its wholly-owned subsidiary Reprints Desk. The company simplifies how organizations procure, access, manage, use, and legally share scholarly journal articles and other content in scientific, technical, and medical (STM) research.
An accomplished technology professional within the digital information industry, Vaghela joins Reprints Desk from ProQuest LLC and will own both strategy and design decisions for Reprints Desk’s existing and future online technology platform. Reprints Desk is currently preparing to launch the next generation of its award-winning software-as-a-service research retrieval platform later in 2017.
Prior to his work with Reprints Desk, Vaghela served as Technology Manager and Project Lead for ProQuest’s Pi2 drug safety software division. Vaghela previously also worked as a software developer at cyberThink Inc. and SunShine Enterprise. He has achieved multiple certifications from Microsoft and is a certified ITIL® professional, trained in consistent and comprehensive documentation of best practice for IT Service Management.
“Raj brings more than 14 years of experience developing scientific workflow solutions for companies in pharmaceuticals and other life science market segments,” noted Chief Sales and Marketing Officer Ian Palmer. “We are extremely pleased that he has agreed to join the Reprints Desk team. His product management expertise will immediately benefit Reprints Desk’s product development program, especially as we expand our technology to serve new users and new markets.”
Vaghela earned a Master’s of Information Technology from Vancouver University Worldwide and a Bachelor of Engineering in Information Technology from Gujarat University. For more information about Raj Vaghela, please visit www.linkedin.com/in/rajnikantv.
About Research Solutions
Research Solutions, Inc. (OTCQB: RSSS) is a pioneer in cloud-based research intelligence and retrieval solutions for R&D-driven organizations. More than 70 percent of the top 25 pharmaceutical companies in the world rely on services delivered by Research Solutions’ wholly owned subsidiary Reprints Desk. The company’s Software-as-a-Service (SaaS) platform provides customers with on-demand access to, and augmented data from, tens of millions of scientific, medical, and technical (STM) documents, helping them to accelerate acquisition at the point of discovery, save time and money, and remain copyright-compliant. For more information, visit www.researchsolutions.com.
About Reprints Desk
Reprints Desk, Inc., a wholly owned subsidiary of Research Solutions, simplifies how organizations procure, access, manage, use, and legally share scholarly journal articles, clinical reprints, patents, and other content in medical affairs and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell, Inc. since 2008. For more information, visit www.reprintsdesk.com.
Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. The Company assumes no obligation to update the cautionary information in this release.
Source: Research Solutions
